Reprogramming to Pluripotency Can Conceal Somatic Cell Chromosomal Instability

English version České info

The discovery that somatic cells are reprogrammable to pluripotency by ectopic expression of a small subset of transcription factors has created great potential for the development of broadly applicable stem-cell-based therapies. One of the concerns regarding the safe use of induced pluripotent stem cells (iPSCs) in therapeutic applications is loss of genomic integrity, a hallmark of various human conditions and diseases, including cancer. Structural chromosome defects such as short telomeres and double-strand breaks are known to limit reprogramming of somatic cells into iPSCs, but whether defects that cause whole-chromosome instability (W-CIN) preclude reprogramming is unknown. Here we demonstrate, using aneuploidy-prone mouse embryonic fibroblasts (MEFs) in which chromosome missegregation is driven by BubR1 or RanBP2 insufficiency, that W-CIN is not a barrier to reprogramming. Unexpectedly, the two W-CIN defects had contrasting effects on iPSC genomic integrity, with BubR1 hypomorphic MEFs almost exclusively yielding aneuploid iPSC clones and RanBP2 hypomorphic MEFs karyotypically normal iPSC clones. Moreover, BubR1-insufficient iPSC clones were karyotypically unstable, whereas RanBP2-insufficient iPSC clones were rather stable. These findings suggest that aneuploid cells can be selected for or against during reprogramming depending on the W-CIN gene defect and present the novel concept that somatic cell W-CIN can be concealed in the pluripotent state. Thus, karyotypic analysis of somatic cells of origin in addition to iPSC lines is necessary for safe application of reprogramming technology.

Vyšlo v časopise: Reprogramming to Pluripotency Can Conceal Somatic Cell Chromosomal Instability. PLoS Genet 8(8): e32767. doi:10.1371/journal.pgen.1002913
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1002913

Souhrn

Zdroje

1. TakahashiK, YamanakaS (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126 : 663–676.

2. HannaJH, SahaK, JaenischR (2010) Pluripotency and cellular reprogramming: facts, hypotheses, unresolved issues. Cell 143 : 508–525.

3. PanopoulosAD, RuizS, Izpisua BelmonteJC (2011) iPSCs: induced back to controversy. Cell Stem Cell 8 : 347–348.

4. TorresEM, WilliamsBR, AmonA (2008) Aneuploidy: cells losing their balance. Genetics 179 : 737–746.

5. HusseinSM, BatadaNN, VuoristoS, ChingRW, AutioR, et al. (2011) Copy number variation and selection during reprogramming to pluripotency. Nature 471 : 58–62.

6. GoreA, LiZ, FungHL, YoungJE, AgarwalS, et al. (2011) Somatic coding mutations in human induced pluripotent stem cells. Nature 471 : 63–67.

7. MarionRM, StratiK, LiH, MurgaM, BlancoR, et al. (2009) A p53-mediated DNA damage response limits reprogramming to ensure iPS cell genomic integrity. Nature 460 : 1149–1153.

8. ParkIH, AroraN, HuoH, MaheraliN, AhfeldtT, et al. (2008) Disease-specific induced pluripotent stem cells. Cell 134 : 877–886.

9. RickeRM, van ReeJH, van DeursenJM (2008) Whole chromosome instability and cancer: a complex relationship. Trends Genet 24 : 457–466.

10. HollandAJ, ClevelandDW (2009) Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nat Rev Mol Cell Biol 10 : 478–487.

11. MusacchioA, SalmonED (2007) The spindle-assembly checkpoint in space and time. Nat Rev Mol Cell Biol 8 : 379–393.

12. KolodnerRD, PutnamCD, MyungK (2002) Maintenance of genome stability in Saccharomyces cerevisiae. Science 297 : 552–557.

13. NasmythK (2002) Segregating sister genomes: the molecular biology of chromosome separation. Science 297 : 559–565.

14. MichorF, IwasaY, VogelsteinB, LengauerC, NowakMA (2005) Can chromosomal instability initiate tumorigenesis? Semin Cancer Biol 15 : 43–49.

15. SchvartzmanJM, SotilloR, BenezraR (2010) Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nature reviews Cancer 10 : 102–115.

16. BakerDJ, DawlatyMM, GalardyP, van DeursenJM (2007) Mitotic regulation of the anaphase-promoting complex. Cellular and molecular life sciences : CMLS 64 : 589–600.

17. RickeRM, van ReeJH, van DeursenJM (2008) Whole chromosome instability and cancer: a complex relationship. Trends in genetics : TIG 24 : 457–466.

18. HollandAJ, ClevelandDW (2009) Boveri revisited: chromosomal instability, aneuploidy and tumorigenesis. Nature reviews Molecular cell biology 10 : 478–487.

19. KulukianA, HanJS, ClevelandDW (2009) Unattached kinetochores catalyze production of an anaphase inhibitor that requires a Mad2 template to prime Cdc20 for BubR1 binding. Dev Cell 16 : 105–117.

20. MalureanuLA, JeganathanKB, HamadaM, WasilewskiL, DavenportJ, et al. (2009) BubR1 N terminus acts as a soluble inhibitor of cyclin B degradation by APC/C(Cdc20) in interphase. Dev Cell 16 : 118–131.

21. LampsonMA, KapoorTM (2005) The human mitotic checkpoint protein BubR1 regulates chromosome-spindle attachments. Nat Cell Biol 7 : 93–98.

22. BakerDJ, JeganathanKB, CameronJD, ThompsonM, JunejaS, et al. (2004) BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nat Genet 36 : 744–749.

23. PichlerA, GastA, SeelerJS, DejeanA, MelchiorF (2002) The nucleoporin RanBP2 has SUMO1 E3 ligase activity. Cell 108 : 109–120.

24. DawlatyMM, MalureanuL, JeganathanKB, KaoE, SustmannC, et al. (2008) Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. Cell 133 : 103–115.

25. BakerDJ, JeganathanKB, CameronJD, ThompsonM, JunejaS, et al. (2004) BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics 36 : 744–749.

26. RickeRM, JeganathanKB, van DeursenJM (2011) Bub1 overexpression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation. J Cell Biol 193 : 1049–1064.

27. BakerDJ, Perez-TerzicC, JinF, PitelK, NiederlanderNJ, et al. (2008) Opposing roles for p16Ink4a and p19Arf in senescence and ageing caused by BubR1 insufficiency. Nature cell biology 10 : 825–836.

28. LiH, ColladoM, VillasanteA, StratiK, OrtegaS, et al. (2009) The Ink4/Arf locus is a barrier for iPS cell reprogramming. Nature 460 : 1136–1139.

29. van ReeJ, ZhouW, LiM, van DeursenJM (2011) Transgenesis in mouse embryonic stem cells. Methods Mol Biol 693 : 143–162.

30. HottaA, EllisJ (2008) Retroviral vector silencing during iPS cell induction: an epigenetic beacon that signals distinct pluripotent states. Journal of cellular biochemistry 105 : 940–948.

31. WernigM, MeissnerA, ForemanR, BrambrinkT, KuM, et al. (2007) In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448 : 318–324.

32. TsaiSY, BouwmanBA, AngYS, KimSJ, LeeDF, et al. (2011) Single transcription factor reprogramming of hair follicle dermal papilla cells to induced pluripotent stem cells. Stem cells 29 : 964–971.

33. ClarkeDJ, JohnsonRT, DownesCS (1993) Topoisomerase II inhibition prevents anaphase chromatid segregation in mammalian cells independently of the generation of DNA strand breaks. J Cell Sci 105(Pt 2):563–569.

34. Van HoofD, PassierR, Ward-Van OostwaardD, PinkseMW, HeckAJ, et al. (2006) A quest for human and mouse embryonic stem cell-specific proteins. Molecular & cellular proteomics : MCP 5 : 1261–1273.

35. LiM, FangX, BakerDJ, GuoL, GaoX, et al. (2010) The ATM-p53 pathway suppresses aneuploidy-induced tumorigenesis. Proc Natl Acad Sci U S A 107 : 14188–14193.

36. ThompsonSL, ComptonDA (2010) Proliferation of aneuploid human cells is limited by a p53-dependent mechanism. J Cell Biol 188 : 369–381.

37. SchvartzmanJM, SotilloR, BenezraR (2010) Mitotic chromosomal instability and cancer: mouse modelling of the human disease. Nat Rev Cancer 10 : 102–115.

38. TorresEM, SokolskyT, TuckerCM, ChanLY, BoselliM, et al. (2007) Effects of aneuploidy on cellular physiology and cell division in haploid yeast. Science 317 : 916–924.

39. WilliamsBR, PrabhuVR, HunterKE, GlazierCM, WhittakerCA, et al. (2008) Aneuploidy affects proliferation and spontaneous immortalization in mammalian cells. Science 322 : 703–709.

40. AzumaY, ArnaoutovA, AnanT, DassoM (2005) PIASy mediates SUMO-2 conjugation of Topoisomerase-II on mitotic chromosomes. Embo J 24 : 2172–2182.

41. AzumaY, ArnaoutovA, DassoM (2003) SUMO-2/3 regulates topoisomerase II in mitosis. J Cell Biol 163 : 477–487.

42. Diaz-MartinezLA, Gimenez-AbianJF, AzumaY, GuacciV, Gimenez-MartinG, et al. (2006) PIASgamma is required for faithful chromosome segregation in human cells. PLoS ONE 1: e53 doi:10.1371/journal.pgen.0010053.

43. BakerDJ, JinF, van DeursenJM (2008) The yin and yang of the Cdkn2a locus in senescence and aging. Cell cycle 7 : 2795–2802.

44. MatsumotoT, BakerDJ, d'UscioLV, MozammelG, KatusicZS, et al. (2007) Aging-associated vascular phenotype in mutant mice with low levels of BubR1. Stroke 38 : 1050–1056.

45. HartmanTK, WengenackTM, PodusloJF, van DeursenJM (2007) Mutant mice with small amounts of BubR1 display accelerated age-related gliosis. Neurobiol Aging 28 : 921–927.

46. van ReeJH, JeganathanKB, MalureanuL, van DeursenJM (2010) Overexpression of the E2 ubiquitin-conjugating enzyme UbcH10 causes chromosome missegregation and tumor formation. J Cell Biol 188 : 83–100.

47. WooRA, PoonRY (2004) Gene mutations and aneuploidy: the instability that causes cancer. Cell Cycle 3 : 1101–1103.

48. LongoL, BygraveA, GrosveldFG, PandolfiPP (1997) The chromosome make-up of mouse embryonic stem cells is predictive of somatic and germ cell chimaerism. Transgenic research 6 : 321–328.

49. TaapkenSM, NislerBS, NewtonMA, Sampsell-BarronTL, LeonhardKA, et al. (2011) Karotypic abnormalities in human induced pluripotent stem cells and embryonic stem cells. Nature biotechnology 29 : 313–314.

50. DonehowerLA, HarveyM, SlagleBL, McArthurMJ, MontgomeryCAJr, et al. (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356 : 215–221.

51. van DeursenJ, HeerschapA, OerlemansF, RuitenbeekW, JapP, et al. (1993) Skeletal muscles of mice deficient in muscle creatine kinase lack burst activity. Cell 74 : 621–631.

52. LaboskyPA, BarlowDP, HoganBL (1994) Mouse embryonic germ (EG) cell lines: transmission through the germline and differences in the methylation imprint of insulin-like growth factor 2 receptor (Igf2r) gene compared with embryonic stem (ES) cell lines. Development 120 : 3197–3204.

53. TakahashiK, OkitaK, NakagawaM, YamanakaS (2007) Induction of pluripotent stem cells from fibroblast cultures. Nat Protoc 2 : 3081–3089.

54. OkadaM, OkaM, YonedaY (2010) Effective culture conditions for the induction of pluripotent stem cells. Biochimica et biophysica acta 1800 : 956–963.

55. MalureanuL, JeganathanKB, JinF, BakerDJ, van ReeJH, et al. (2010) Cdc20 hypomorphic mice fail to counteract de novo synthesis of cyclin B1 in mitosis. The Journal of cell biology 191 : 313–329.